The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.
By Michael Schroeder Friday, April 1, 2022 3:12 PM
The IBC Foundation Institute for Health Equity's initial focus areas will include digital health, cultural competence in medicine and maternal health. The money committed for the creation of the Institute will be spent over a five-year period.
The second quarter of 2022 kicked off with a new life sciences company joining the public markets, but not via an IPO or merger. Becton Dickinson on Friday completed the spinoff of its diabetes care business, Embecta, which now trades on the Nasdaq.
At the MedCity INVEST conference this week, a panel discussion highlighted the benefits of going public in Canada as an alternative path for young growth stage companies to raise capital.
By Halima Ahmadi-Montecalvo Friday, April 1, 2022 9:00 AM
The health crisis in Black communities isn't solely due to lack of access to care. Much of it also stems from well-documented racial disparities and biases, such as biases around pain perception and treatment recommendations.
In this episode of the MedCity Pivot Podcast, Jonathan Bush talks about his latest venture - Zus Health - through which he wants to help digital health companies share data to create a universal patient off of which new products can be created to serve payers, providers and others with the ultimate goal of improving patient outcomes.
No comments